Ownership Summary
The institutional landscape for Northwest Biotherapeutics Inc (OTC:NWBO) includes 4 filers as of the latest reporting cycle ending December 2025.
- The percentage of Northwest Biotherapeutics owned by institutions changed from 0.0% in September 2025 to 0.0% in December 2025, marking a slight down trend.
- The company experienced a 3.10% quarterly change in institutional shares held, alongside a decrease of 55.56% in total owners annually.
- Among the 4 institutional holders of Northwest Biotherapeutics, 1 added to their stakes while 0 trimmed their positions and 3 held steady.
- The total number of shares held by institutions in Northwest Biotherapeutics increased to 99.77K as of December 2025, a net change of up by 3.00K shares quarter on quarter, and down 115.11K shares year over year.
- Opus Capital Group, LLC's holding of 60.15K shares as of December 31, 2025 makes it the primary institutional investor in Northwest Biotherapeutics, owning 0.00% of the stock.
- Among the most significant buyers of Northwest Biotherapeutics during December 2025 were Ethos Financial Group, LLC (3.00K).
- The top 4 institutional holders of Northwest Biotherapeutics for the quarter ending December 2025 included Opus Capital Group, LLC (60.15K), Ethos Financial Group, LLC (28.35K), ADVISORS MANAGEMENT GROUP INC /ADV (10.27K), Coston, McIsaac & Partners (1.00K).